Hydrocephalus 2008
Sept. 17th - 20th , Hannover, Germany

Sponsors
Social Program
Author instructions

ISHCSF
Our new society
.
For more information click here!

 


Thanks for your abstract submission !
Call for abstracts  

Abstracts must be submitted electronically: click here.
Modifying abstracts is possible until the 15th June.
Deadline for submission: 15th June 2008

The 2nd international and interdisciplinary congress "Hydrocephalus 2008" will challenge established as well as non-traditional concepts in the diagnosis, treatment and outcome assessment of hydrocephalus and focus on new clinical and experimental research issues (e.g. "intelligent shunt designs", new concepts in modelling of the CSF system and CSF dynamics, non-invasive diagnostic tools, functional and metabolic imaging, biomarkers, neuropsychological and cognitive function and outcome, aspects of dementia, qualitiy of life and rehabilitation, "neuromodulative" pharmacological treatment and "CNS-drug delivery").

All accepted abstracts will be published in a supplement of Clinical Neurology and Neurosurgery (www.elsevier.com) prior to the conference and will be handed out during the congress. Also, a selection of abstract submissions will published as short papers in a special issue of CNN.

Abstracts will be accepted preferrably as oral presentation. Upon number of submissions selected abstracts will be presented as posters.

Authors will receive an e-mail notification about the decision on their abstract latest until 15th of July.

Please note: Presentation of the accepted abstract as oral or poster presentation requires completed registration latest upon abstract e-mail notification!

 

Scientific Topics

  • CSF physics and dynamics
  • Cerebrospinal fluid function and modeling of cerebrospinal fluid function
  • Dementia, quality of life, economy and health care, rehabilitation
  • Neuropsychology and cognition in hydrocephalus
  • Outcome assessment
  • Neuroimaging, functional imaging and non-invasive diagnostics
  • Pediatric hydrocephalus and the adolescent hydrocephalic patient
  • "Intelligent" shunt designs (e.g. telemetry, adjustable and antimicrobial shunts)
  • ETV in hydrocephalus
  • Brain metabolism, biomarkers and biophysics
  • Pharmaceutical modulation of central nervous system function ("CNS drug delivery")
  • Co-morbidity in hydrocephalus, classification and etiology
  • Epidemiology
  • Registries and clinical trials in hydrocephalus
  • Experimental hydrocephalus
  • Advances in "image-guided" surgical approaches for hydrocephalus